BRKR Bruker Earnings and EPS analysis

  1. Stocks
  2. Healthcare
  3. NASDAQ: BRKR
  4. Earnings
?
Relative Growth: Rel. Growth: 15
Relative Strength: Rel. Strength: 86
Relative Valuation: Rel. Valuation: 22
Relative Profitability: Rel. Profitability: 30

EPS in 2026 (TTM): -$0.24

Last Report Period Date: Mar 31, 2026

According to the most recent financial data from March 2026, the EPS for the trailing twelve months is -$0.24. Bruker's EPS for 2025 amounted to -$0.15, marking a drop from $0.76 in 2024. During the quarterly period ending on Mar 31, 2026, BRKR's EPS stood at $0.02.

BRKR earnings history

Historical annual and quarterly earnings per share (EPS) data for Bruker
EPS (TTM)
-$0.24
EPS Growth YoY (Quarterly)
-81.8%
EPS (Quarterly)
$0.02
EPS Growth (Quarterly)
-80%

Bruker had an annual EPS of -$0.15, indicating a drop of 119.7% from $0.76 in 2024. The quarterly per-share earnings for the period ending Mar 31, 2026, was $0.02, indicating a 81.8% decrease from the same quarter last year. BRKR's 12-month EPS stands at -$0.24 as of March 2026. Bruker's annual EPS in 2024 stood at $0.76, a 74% decrease year-over-year.

BRKR earnings chart

BRKR EPS growth history

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
-81.8%
EPS growth YoY
-119.7%
EPS growth 3Y avg
N/A
EPS growth 5Y avg
N/A

Bruker has registered a decrease in EPS of 81.8% during the last 12 months (YoY, quarterly).

BRKR Earnings Waterfall

Breakdown of revenue, profit and net income for Bruker

BRKR Earnings vs Peers

What are the earnings of BRKR compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
A Agilent Technologies Inc 25.48 3.4% 3.1% 14.5%
TMO Thermo Fisher Scientific Inc 25.59 7.2% 0% 2%
ILMN Illumina Inc 29.7 171.1% N/A 4.1%
DHR Danaher Corp 34.32 -4.9% -19.7% 0.4%
AME Ametek Inc 35.7 7.9% 8.4% 11.1%
GE General Electric Co 43.68 35.8% 447.4% 12.1%
WAT Waters Corp 45.47 0.5% -2.9% 5.2%
BIO Bio-Rad Laboratories Inc 47.19 142.6% N/A -26.3%
BRKR Bruker Corp N/A -119.7% N/A N/A

All data is based on quarterly TTM periods, unless otherwise specified.